Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

FeetMe

Explore full profile

Proposing a medical device connected to pressure sensors soles

Paris, FranceFounded 2013Health Tech & Medtech
Valuation $25–50M Last recorded · 2019
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for FeetMe and the history behind them.

About FeetMe

FeetMe, established in Paris in 2013, operates at the intersection of medical devices and digital health, focusing on mobility disorders. The company was founded by Alexis Mathieu who, after studying at École Polytechnique and UC Berkeley, aimed to address unmet clinical needs within the rehabilitation community. Since its inception, the company has secured $12.7 million in funding over four rounds, including a significant $10.4 million Series A round in September 2019 led by LBO France.

Read full description

The core of FeetMe's business is a platform for real-world disease diagnostics, monitoring, and rehabilitation centered on movement data. The company's main offering is the FeetMe Monitor, a system of medical-grade connected insoles designed for gait and posture analysis in real-life conditions. These insoles are equipped with a suite of sensors, including 18 pressure sensors and 6-axis motion sensors, which collect precise data on a patient's functional capacity. This data is then processed by proprietary algorithms to provide over 20 metrics for every step, such as stride time, cadence, and pressure distribution. The system is designed for seamless integration into a patient's daily life, featuring wireless charging and Bluetooth connectivity.

FeetMe's business model targets healthcare providers, including hospitals and rehabilitation clinics, as well as the pharmaceutical industry for clinical trials. The collected data enables clinicians to remotely monitor patients, track disease progression for conditions like Parkinson's disease, multiple sclerosis, and diabetic foot problems, and tailor rehabilitation programs. For pharmaceutical clients, the technology offers a method to gather real-world evidence and high-precision measurements, potentially accelerating clinical research. The product ecosystem includes the smart insoles, a mobile application for real-time biofeedback and data collection, and a web-based dashboard for in-depth analysis and reporting by healthcare professionals.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2013
Headquarters
Paris, France
Employees
18
Open positions
None listed
Dealroom signal
61.3/100
Industry
Health
Sub-industry
Medical Devices, Health Platform
Sector
Health Tech & Medtech, Personal Health, Diabetes, Analytics, Remote Monitoring
Technology
Hardware, Deep Tech, Connected Device, Recognition Technology, IoT InternetOfThings
Business model
Manufacturing
Client focus
b2b

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
CONVERTIBLEOther financing Mar 2022 $0 — SOSV —
SERIES AOther financing Sep 2019 $10M $41M Partech · Eurazeo · SOSV · LBO France ↗
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

FeetMe website traffic

Latest recorded traffic for FeetMe is 0 monthly website visits, down 100% over the last three months. FeetMe's team declined 14.3% over the past year.

Latest monthly visits0 3-month web change-100% 1-year team growth-14.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series A5 investors entered at this stage

Other known investors6 additional known investors

  • EIT Health
  • École Polytechnique - IP Paris
  • IP Paris
  • Agoranov
  • Amine MAROUF
  • Paris Saclay Seed Fund
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇫🇷 France87.5%
🇩🇪 Germany12.5%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about FeetMe on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See FeetMe’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.